Chemed (NYSE:CHE) Issues FY 2026 Earnings Guidance

Chemed (NYSE:CHE) issued an update on its FY 2026 earnings guidance on Tuesday. The company provided earnings per share guidance of 25.000-25.750 for the period, compared to the consensus estimate of 24.010. The company issued revenue guidance of -.

Analysts Set New Price Targets

A number of research analysts have recently commented on CHE shares. Royal Bank Of Canada upped their price target on Chemed from $422.00 to $436.00 and gave the company a “sector perform” rating in a research report on Monday, April 27th. Bank of America upped their price objective on shares of Chemed from $450.00 to $510.00 and gave the company a “neutral” rating in a report on Thursday, July 9th. Zacks Research upgraded shares of Chemed from a “strong sell” rating to a “hold” rating in a research report on Monday, April 27th. Weiss Ratings upgraded shares of Chemed from a “hold (c-)” rating to a “hold (c)” rating in a research note on Friday, July 17th. Finally, Wall Street Zen lowered shares of Chemed from a “buy” rating to a “hold” rating in a research report on Monday, June 8th. One analyst has rated the stock with a Buy rating and five have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $480.25.

Chemed Stock Performance

Shares of NYSE CHE traded up $6.75 during mid-day trading on Tuesday, hitting $516.09. The company had a trading volume of 198,344 shares, compared to its average volume of 222,959. The company has a current ratio of 0.85, a quick ratio of 0.83 and a debt-to-equity ratio of 0.11. Chemed has a 1 year low of $365.20 and a 1 year high of $520.01. The company has a market capitalization of $6.85 billion, a price-to-earnings ratio of 28.12, a P/E/G ratio of 1.88 and a beta of 0.52. The stock’s 50-day moving average price is $459.92 and its 200-day moving average price is $434.09.

Chemed Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, June 16th. Shareholders of record on Thursday, May 28th were issued a dividend of $0.60 per share. This represents a $2.40 dividend on an annualized basis and a yield of 0.5%. The ex-dividend date of this dividend was Thursday, May 28th. Chemed’s payout ratio is presently 13.08%.

Insider Activity

In related news, CEO Kevin J. Mcnamara sold 2,000 shares of the business’s stock in a transaction that occurred on Friday, May 1st. The shares were sold at an average price of $421.13, for a total transaction of $842,260.00. Following the completion of the transaction, the chief executive officer owned 90,219 shares of the company’s stock, valued at approximately $37,993,927.47. The trade was a 2.17% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Andrea R. Lindell sold 1,347 shares of the company’s stock in a transaction that occurred on Tuesday, June 9th. The stock was sold at an average price of $447.33, for a total transaction of $602,553.51. Following the sale, the director directly owned 4,578 shares in the company, valued at $2,047,876.74. This trade represents a 22.73% decrease in their position. The disclosure for this sale is available in the SEC filing. Corporate insiders own 3.33% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the company. Los Angeles Capital Management LLC bought a new position in shares of Chemed in the fourth quarter worth $26,000. Global Retirement Partners LLC grew its position in Chemed by 200.0% during the fourth quarter. Global Retirement Partners LLC now owns 87 shares of the company’s stock worth $37,000 after buying an additional 58 shares in the last quarter. Geneos Wealth Management Inc. grew its position in Chemed by 330.4% during the first quarter. Geneos Wealth Management Inc. now owns 99 shares of the company’s stock worth $61,000 after buying an additional 76 shares in the last quarter. Employees Retirement System of Texas bought a new position in Chemed in the 3rd quarter worth about $64,000. Finally, Caitong International Asset Management Co. Ltd increased its stake in Chemed by 5,333.3% in the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 163 shares of the company’s stock worth $73,000 after acquiring an additional 160 shares during the last quarter. 95.85% of the stock is currently owned by hedge funds and other institutional investors.

About Chemed

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.